Mechanisms for Activation of Beige Adipose Tissue in Humans

PHASE2RecruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

December 7, 2020

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
PreDiabetes
Interventions
DRUG

Placebo

Participants will take one pill (placebo) daily for the first week and two pills daily for the remaining 15 weeks.

DRUG

Mirabegron

Participants will take one pill (50mg Mirabegron) daily for the first week. For week two, participants will take two pills (50mg and 25mg Mirabegron). Unless there are side effects, for the remaining 14 weeks participants will take two pills (50mg each) daily.

DRUG

Mirabegron 50 MG

Participants will take one pill (50mg Mirabegron) daily between visit 2 and visit 3

DRUG

Mirabegron 100 mg

participants will be given 6 weeks of mirabegron (25 mg) and will take 1 pill once per day for 4-6 weeks. Next participants will be given 6 weeks of mirabegron (50 mg) and take 1 pill once per day for 4-6 weeks. Last participants will be given 6 weeks of mirabegron (100 mg) and take 1 pill once per day for 4-6 weeks.

Trial Locations (1)

40536

RECRUITING

University of Kentucky, Lexington

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Philip Kern

OTHER